345830 Galectin-3, Human, Recombinant, E. coli

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: CBP30, CBP35, εBP, L-29, L-34, Mac-2

345830
View Pricing & Availability

Overview

Replacement Information

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
345830-100UG
Retrieving availability...
—
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 100 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewRecombinant, human galectin-3 expressed in E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
      Catalogue Number345830
      Brand Family Calbiochem®
      SynonymsCBP30, CBP35, εBP, L-29, L-34, Mac-2
      References
      ReferencesLegendre, H., et al. 2003. Mod. Pathol. 16, 491.
      Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
      Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
      Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
      Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
      Oda, Y., et al. 1991. Gene 99, 279.
      Product Information
      FormLyophilized
      FormulationLyophilized from diH₂O.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: ≤1.0 EU/µg galectin-3
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Galectin-3, Human, Recombinant, E. coli SDS

      Title

      Safety Data Sheet (SDS) 

      Galectin-3, Human, Recombinant, E. coli Certificates of Analysis

      TitleLot Number
      345830

      References

      Reference overview
      Legendre, H., et al. 2003. Mod. Pathol. 16, 491.
      Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
      Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
      Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
      Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
      Oda, Y., et al. 1991. Gene 99, 279.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-June-2008 RFH
      SynonymsCBP30, CBP35, εBP, L-29, L-34, Mac-2
      DescriptionRecombinant, human galectin-3 expressed in and purified from E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
      FormLyophilized
      FormulationLyophilized from diH₂O.
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxin: ≤1.0 EU/µg galectin-3
      SolubilityReconstitute in sterile PBS. For use in carbohydrate binding studies, lactose should be removed by dialysis.
      Storage -20°C
      Avoid freeze/thaw
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
      Toxicity Standard Handling
      ReferencesLegendre, H., et al. 2003. Mod. Pathol. 16, 491.
      Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
      Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
      Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
      Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
      Oda, Y., et al. 1991. Gene 99, 279.